These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30675173)

  • 1. Dermatomyositis associated with omalizumab therapy for severe asthma: a case report.
    Jeimy S; Basharat P; Lovegrove F
    Allergy Asthma Clin Immunol; 2019; 15():4. PubMed ID: 30675173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
    Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
    Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
    J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of juvenile-onset clinically amyopathic dermatomyositis.
    Gerami P; Walling HW; Lewis J; Doughty L; Sontheimer RD
    Br J Dermatol; 2007 Oct; 157(4):637-44. PubMed ID: 17596148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis.
    Cao H; Parikh TN; Zheng J
    Clin Rheumatol; 2009 Aug; 28(8):979-84. PubMed ID: 19294477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].
    Gan YZ; Li YH; Zhang LH; Ma L; He WW; Jin YB; An Y; Li ZG; Ye H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1001-1008. PubMed ID: 33331305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.
    Walling HW; Gerami P; Sontheimer RD
    Paediatr Drugs; 2010; 12(1):23-34. PubMed ID: 20034339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects.
    Sontheimer RD
    Dermatol Clin; 2002 Jul; 20(3):387-408. PubMed ID: 12170874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
    Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
    Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report.
    Kishi T; Tani Y; Okiyama N; Mizuochi K; Ichimura Y; Harigai M; Nagata S; Miyamae T
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):34. PubMed ID: 33740993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When a Painful Rash Keeps Recurring: A Case of Seronegative Amyopathic Dermatomyositis Without Neurological Sequelae.
    Harazeen A; Walter B; Li X; Patel C
    Cureus; 2023 Jul; 15(7):e42727. PubMed ID: 37654955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute urticaria associated to omalizumab treatment in a child with asthma].
    Velarde-Domínguez T; Pantoja-Alcantar JM; Martínez-Sáenz NP
    Rev Alerg Mex; 2012; 59(4):209-13. PubMed ID: 24008031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-MDA5 Antibody-Positive Interstitial Pneumonia with Autoimmune Features Presenting as Amyopathic Hypodermatitic Dermatomyositis: A Case Report.
    Mihailescu ML; Edens C; Hoffman MD
    Case Rep Dermatol; 2021; 13(1):222-229. PubMed ID: 34054457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyopathic and anti-TIF1 gamma-positive dermatomyositis: analysis of a monocentric cohort and proposal to update diagnostic criteria.
    Didona D; Juratli HA; Scarsella L; Keber U; Eming R; Hertl M
    Eur J Dermatol; 2020 Jun; 30(3):279-288. PubMed ID: 32666928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation.
    Norman G; Faria R; Paton F; Llewellyn A; Fox D; Palmer S; Clifton I; Paton J; Woolacott N; McKenna C
    Health Technol Assess; 2013 Nov; 17(52):1-342. PubMed ID: 24267198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis.
    Arasi S; Costa S; Magazzù G; Ieni A; Crisafulli G; Caminiti L; Chiera F; Vaccaro M; Del Giudice MM; Pajno GB
    Ital J Pediatr; 2016 Mar; 42():32. PubMed ID: 27000314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab as a Provoking Factor for Venous Thromboembolism.
    Oblitas CM; Galeano-Valle F; Vela-De La Cruz L; Del Toro-Cervera J; Demelo-Rodríguez P
    Drug Target Insights; 2019; 13():1177392819861987. PubMed ID: 31320796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment challenges in clinically amyopathic dermatomyositis: A case series and review of new therapeutic options for skin involvement.
    Rodríguez-Tejero A; López-Espadafor B; Montero-Vílchez T; Sánchez-Díaz M; Arias-Santiago S; Molina-Leyva A
    Dermatol Ther; 2021 May; 34(3):e14942. PubMed ID: 33719170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.